Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.39 |
| ▸ | OGA | O60502 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803822 | 0.85 | HPGD (0.42) | KMT2AGAAKDM4EALDH1A1TAS1R3 | |
| SCHEMBL15896811 | 0.79 | ALDH1A1 (0.42) | ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL786186 | 0.77 | CYP3A4 (0.51) | EDNRAKMT2AGAAALDH1A1HPGD | |
| SCHEMBL22404286 | 0.73 | EDNRA (0.56) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 | |
| SCHEMBL1746047 | 0.72 | PTGS2 (0.56) | EDNRAKMT2AALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL805660 | 0.72 | EDNRA (0.55) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 | |
| SCHEMBL4996294 | 0.71 | EDNRA (0.54) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 | |
| SCHEMBL10204938 | 0.71 | EDNRA (0.54) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 | |
| SCHEMBL805662 | 0.71 | EDNRA (0.54) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 | |
| SCHEMBL14032401 | 0.71 | EDNRA (0.54) | EDNRAKMT2AKDM4EALDH1A1TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071661-A1 | Ionic Liquid Solvents | EBP, PAICS, HACD3 | EDNRA 3492/4885KMT2A 3968/4885GAA 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.